| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |